← All trials
NCT03648892
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Sep 21, 2018
- Primary completion
- Mar 31, 2022
- Completion date
- Feb 17, 2023
- First posted
- Aug 28, 2018
- Last posted
- Jul 11, 2023
- Enrollment
- 61
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Lead sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Overall official - principal investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.